Mariner’s Tango Therapeutics TNGX Stock Holding History

Mariner’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,897	Closed	-$86.5K	–	3289
2024 Q1	$86.5K	Buy	10,897 +145	+1%	+$1.55K	﹤0.01%	2957
2023 Q4	$106K	Buy	+10,752	New	+$93.3K	﹤0.01%	2847

Other funds holding TNGX

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

SCA

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Mariner's TNGX Position: Q2 2024 in Review

Mariner sold out of Tango Therapeutics (TNGX) in Q2 2024, closing a stake of 10,897 shares — an estimated $86.5K sold.

Mariner first reported a position in TNGX in Q4 2023 and held it in 2 quarters. The position peaked at $106K in Q4 2023. 119 funds tracked by Wall St. Rank hold TNGX as of Q2 2024.

Mariner reported no remaining Tango Therapeutics position as of Q2 2024 after selling out during the quarter.
Mariner sold 10,897 Tango Therapeutics shares in Q2 2024, an estimated $86.5K.
Mariner first reported a position in Tango Therapeutics in Q4 2023 and held it in 2 quarters.
Mariner's Tango Therapeutics position peaked at $106K in Q4 2023.
119 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2024.

Based on Mariner's 13F filing for Q2 2024, filed 13 Aug 2024.